Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

9551.   Asero R, Mistrello G, Roncarolo D, Amato S.  Walnut-induced anaphylaxis with cross-reactivity to hazelnut and Brazil nut. J Allergy Clin Immunol. 2004 Feb;113(2):358-60.

9552.   Bannon GA.  What makes a food protein an allergen? Curr Allergy Asthma Rep. 2004 Jan;4(1):43-6. Review.

9553.   Barbier N, Paul C, Luger T, Allen R, De Prost Y, Papp K, Eichenfield LF, Cherill R, Hanifin J. Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. Br J Dermatol. 2004 Jan;150(1):96-102.

9554.   Bhagyalakshmi O, Prasad CE. Spirometric studies of the subjects in an active area of Hyderabad A.P. Indian J envir Hlth 2002; 44(2): 113-17.

9555.   Bukantz SC, Lockey RF. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy. Clin Allergy Immunol. 2004;18:711-27. Review.

9556.   Burks W.  Food allergens. Clin Allergy Immunol. 2004;18:319-37.

9557.   Ciprandi G, Tosca MA, Milanese M, Schenone G, Ricca V. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.Allerg Immunol (Paris). 2004 Feb;36(2):67-70, 72.

9558.   Francis JN, Jacobson MR, Lloyd CM, Sabroe I, Durham SR, Till SJ. CXCR1+CD4+ T cells in human allergic disease. J Immunol. 2004 Jan 1;172(1):268-73.

9559.   Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med. 2004 Feb 17;140(4):278-89.

9560.   Hamid Q.  Eosinophils in allergic inflammation. J Allergy Clin Immunol. 2004 Jan;113(1):182-4.

9561.   Holgate ST. The epidemic of asthma and allergy. J R Soc Med. 2004 Mar;97(3):103-10.

9562.   Jacobsen L.  Immunotherapy for the prevention of allergic diseases. Clin Allergy Immunol. 2004;18:529-40.

9563.   Kemp SF, Deshazo RD. Prevention and treatment of anaphylaxis. Clin Allergy Immunol. 2004;18:729-54.

9564.   Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest. 2004 Mar;113(5):651-7. Review.

9565.   Malling HJ. Immunotherapy for allergic rhinoconjunctivitis. Clin Allergy Immunol. 2004;18:495-509.

9566.   Morinville V, Bernard C, Forget S. Foveolar hyperplasia secondary to cow's milk protein hypersensitivity presenting with clinical features of pyloric stenosis. J Pediatr Surg. 2004 Jan;39(1):E29-31.

9567.   Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med. 2004 Feb 9;164(3):317-9.

9568.   Pourpak Z, Mansouri M, Mesdaghi M, Kazemnejad A, Farhoudi A. Wheat allergy: clinical and laboratory findings. Int Arch Allergy Immunol. 2004 Feb;133(2):168-73. Epub 2004 Feb 05.

9569.   Ranta PM, Ownby DR. A review of natural-rubber latex allergy in health care workers. Clin Infect Dis. 2004 Jan 15;38(2):252-6. Epub 2003 Dec 19.

9570.   Sandstrom MH, Faergemann J. Prognosis and prognostic factors in adult patients with atopic dermatitis: a long-term follow-up questionnaire study. Br J Dermatol. 2004 Jan;150(1):103-10.

9571.   Szebeni J. Hypersensitivity reactions to radiocontrast media: the role of complement activation. Curr Allergy Asthma Rep. 2004 Jan;4(1):25-30. Review.

9572.   Till SJ, Durham SR. Immunological responses to allergen immunotherapy. Clin Allergy Immunol. 2004;18:85-104.

9573.   Vanto T, Helppila S, Juntunen-Backman K, Kalimo K, Klemola T, Korpela R, Koskinen P. Prediction of the development of tolerance to milk in children with cow's milk hypersensitivity. J Pediatr. 2004 Feb;144(2):218-22.

9574.   Widdowson KL, Elliott JD, Veber DF, Nie H, Rutledge MC, McCleland BW, Xiang JN, Jurewicz AJ, Hertzberg RP, Foley JJ, Griswold DE, Martin L, Lee JM, White JR, Sarau HM.  Evaluation of potent and selective small-molecule antagonists for the CXCR2 chemokine receptor. J Med Chem. 2004 Mar 11;47(6):1319-21.

9575.   Yunginger JW.  In vitro tests to monitor efficacy of immunotherapy. Clin Allergy Immunol. 2004;18:115-23. Review.


9576.   Arakawa S, Hatano Y, Katagiri K. Differential expression of mRNA for Th1 and Th2 cytokine-associated transcription factors and suppressors of cytokine signalling in peripheral blood mononuclear cells of patients with atopic dermatitis. Clin Exp Immunol. 2004 Mar;135(3):505-10.

9577.   Becker Y. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers—a review and hypothesis. Virus Genes. 2004 Jan;28(1):5-18. Review.

9578.   Bhargava P, Gammon D, McCormick MJ. Hypersensitivity and idiosyncratic reactions to oxaliplatin. Cancer. 2004 Jan 1;100(1):211-2.

9579.   Bloebaum RM, Dharajiya N, Grant JA. Mechanisms of IgE-mediated allergic reactions. Clin Allergy Immunol. 2004;18:65-84.

9580.   Blumenthal MN.  New thoughts regarding the genetics of atopy. Am J Respir Crit Care Med. 2004 Mar 1;169(5):555-6.

9581.   Boyce JA.  The biology of the mast cell. Allergy Asthma Proc. 2004 Jan-Feb;25(1):27-30.

9582.   Callahan MK, Ransohoff RM. Analysis of leukocyte extravasation across the blood-brain barrier: conceptual and technical aspects. Curr Allergy Asthma Rep. 2004 Jan;4(1):65-73.

9583.   Cathcart K, Pinilla-Ibarz J, Korontsvit T, Schwartz J, Zakhaleva V, Papadopoulos EB, Scheinberg DA. A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia. Blood. 2004 Feb 1;103(3):1037-42. Epub 2003 Sep 22.

9584.   Gustafsson D, Andersson K. Effect of indoor environmental factors on development of atopic symptoms in children followed up to 4 years of age. Paediatr Perinat Epidemiol. 2004 Jan;18(1):17-25.

9585.   Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol. 2004 Feb;113(2):334-40.

9586.   Huang SH, Frydas S, Kempuraj D, Barbacane RC, Grilli A, Boucher W, Letourneau R, Madhappan B, Papadopoulou N, Verna N, De Lutiis MA, Iezzi T, Riccioni G, Theoharides TC, Conti P.  Interleukin-17 and the interleukin-17 family member network. Allergy Asthma Proc. 2004 Jan-Feb;25(1):17-21.

9587.   Kabesch M, Lauener RP. Why Old McDonald had a farm but no allergies: genes, environments, and the hygiene hypothesis. J Leukoc Biol. 2004 Mar;75(3):383-7. Epub 2004 Jan 02.

9588.   Kelly FJ, Sandstrom T.  Air pollution, oxidative stress, and allergic response. Lancet. 2004 Jan 10;363(9403):95-6.

9589.   Klostermann B, Bellinghausen I, Bottcher I, Petersen A, Becker WM, Knop J, Saloga J.  Modification of the human allergic immune response by allergen-DNA-transfected dendritic cells in vitro. J Allergy Clin Immunol. 2004 Feb;113(2):327-33.

9590.   Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, Carr VA, Robinson DS. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet. 2004 Feb 21;363(9409):608-15.

9591.   Saikai T, Tanaka H, Sato N, Abe S, Matsuura A. Mushroom plant workers experience a shift towards a T helper type 2 dominant state: contribution of innate immunity to spore antigen. Clin Exp Immunol. 2004 Jan;135(1):119-24.

9592.   Soeria-Atmadja D, Zorzet A, Gustafsson MG, Hammerling U. Statistical evaluation of local alignment features predicting allergenicity using supervised classification algorithms. Int Arch Allergy Immunol. 2004 Feb;133(2):101-12. Epub 2004 Jan 21.


9593.   Bousquet J. Primary and secondary prevention of allergy and asthma by allergen therapeutic vaccines. Clin Allergy Immunol. 2004;18:105-14.

9594.   Gupta P, Grammer LC. Administration of allergen vaccines. Clin Allergy Immunol. 2004;18:481-93.


9595.   Akpek EK, Dart JK, Watson S, Christen W, Dursun D, Yoo S, O'Brien TP, Schein OD, Gottsch JD. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology. 2004 Mar;111(3):476-82.

9596.   Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest. 2004 Feb;125(2 Suppl):52S-60S; quiz 60S-61S. Review.

9597.   Ng KH, Chong D, Wong CK, Ong HT, Lee CY, Lee BW, Shek LP. Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study. Pediatrics. 2004 Feb;113(2):e116-21.

9598.   Portnoy JM, Dinakar C. Review of cetirizine hydrochloride for the treatment of allergic disorders. Expert Opin Pharmacother. 2004 Jan;5(1):125-35.

9599.   Valovirta E, Passalacqua G, Canonica WG. Non-injection routes for immunotherapy of allergic diseases. Clin Allergy Immunol. 2004;18:607-23.

9600.   Wilson AM, O'Byrne PM, Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med. 2004 Mar 1;116(5):338-44.